Search / Trial NCT06221215

Clinical Analysis of Early Hormones Between Patients With Traumatic Brain Injury and Cerebral Hemorrhage

Launched by GENERAL HOSPITAL OF NINGXIA MEDICAL UNIVERSITY · Jan 14, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Traumatic Brain Injury Cerebral Hemorrhage Hormone Trauma

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥ 18 years old.
  • 2. The patient was clearly diagnosed as craniocerebral injury.
  • 3. The Glasgow score on admission was 3-12 (moderate and severe).
  • 4. It has complete preclinical data.
  • Exclusion Criteria:
  • 1. Complicated with other severe visceral injuries or severe systemic fractures.
  • 2. Suffered from craniocerebral tumors, endocrine diseases, cardiovascular diseases, depression, sleep and mental disorders.
  • 3. In the past month, there are people who receive immune and hormone therapy.
  • 4. Women during pregnancy and lactation.
  • 5. Where there is a logical or common sense error in the data entered.
  • 6. The lack of too much clinical data related to this study.

About General Hospital Of Ningxia Medical University

The General Hospital of Ningxia Medical University is a leading healthcare institution dedicated to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital integrates cutting-edge research with its extensive clinical expertise to facilitate innovative studies across various medical fields. With a commitment to improving health outcomes, the General Hospital of Ningxia Medical University collaborates with researchers and healthcare professionals to conduct rigorous trials that adhere to the highest ethical and scientific standards, ultimately contributing to the advancement of medical knowledge and the development of new therapies.

Locations

Yinchuan, Ningxia, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0